Literature DB >> 2278057

Diagnosis of Plasmodium vivax malaria using a specific deoxyribonucleic acid probe.

W A Relf1, R E Boreham, P Tapchaisri, S Khusmith, A Healey, P Upcroft, S Tharavanij, C Kidson.   

Abstract

A deoxyribonucleic acid (DNA) probe which specifically distinguishes Plasmodium vivax from P. falciparum malaria has been derived from a P. vivax genomic DNA library. This probe, VPL101, consists of 3.2 kilobase pairs and does not hybridize with up to 6 micrograms of human or P. falciparum DNA. VPL101 contains at least two copies of a 205 base pair repeat sequence. The subcloned repeat probe, VPL101/5, reacted with 73 of 76 microscopically diagnosed P. vivax samples but not with any of 17 human DNA samples or any of 8 P. falciparum DNA samples from cultured parasites. It was possible to detect P. vivax in mixed infections in which only P. falciparum parasites were identifiable by microscopy. This P. vivax DNA probe provides a useful epidemiological tool for malaria control programmes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278057     DOI: 10.1016/0035-9203(90)90128-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

Review 1.  Mixed-species Plasmodium infections of humans.

Authors:  F E McKenzie; W H Bossert
Journal:  J Parasitol       Date:  1997-08       Impact factor: 1.276

Review 2.  DNA probes and PCR for diagnosis of parasitic infections.

Authors:  J B Weiss
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen.

Authors:  J Russ Forney; Chansuda Wongsrichanalai; Alan J Magill; Leslie G Craig; Jeeraphat Sirichaisinthop; Christian T Bautista; R Scott Miller; Christian F Ockenhouse; Kent E Kester; Naomi E Aronson; Ellen M Andersen; Higinio A Quino-Ascurra; Carlos Vidal; Kimberly A Moran; Clinton K Murray; Caroline Cady DeWitt; D Gray Heppner; Kevin C Kain; W Ripley Ballou; Robert A Gasser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.